Clinical Trial Update: Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating nitroglycerin, 5-fluorouracil, and radiation therapy for rectal cancer; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• NITROGLYCERIN (Nitroglycerin)
• Radiation therapy

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Rectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2021-01-14